Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Trial of Acute Normovolemic Hemodilution (ANH) in Patients Undergoing Cytoreductive Surgery for Ovarian Cancer

NCT06290193 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT06290193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06290193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Trial of Acute Normovolemic Hemodilution (ANH) in Patients Undergoing Cytoreductive Surgery for Ovarian Cancer
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Phase 2
Overall status
Recruiting
Start date
February 23, 2024
Completion date
February 23, 2029
Enrollment
86 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

fallopian tube cancer, fallopian tube cancer stage iiic, fallopian tube cancer stage iv, fallopian tube carcinoma, ovarian cancer, ovarian cancer stage iiic, ovarian cancer stage iv, ovarian carcinoma, peritoneal cancer, peritoneal carcinoma